Endovia Health Sciences, Inc. EDVA
Set alert
0.17 USD 0.00 +1.24%
At close · Oct 30
0.18 +0.01 +4.59%
After hours · Oct 30, 7:45 PM ET
0.1633 Day range 0.175
0.135 52-week range 6.56
- YTD
- -93.76%
- 1 year
- -97.38%
- Open
- 0.1679
- Prev close
- 0.17
- Mkt cap
- 1.96M
- Vol
- 657.81K
- Avg vol
- 4.09M
- EPS
- -21.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1633
- High
- 0.175
3M chart
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
Financials — quick view
EDVA Revenue — quarterly 0
EDVA Net income — quarterly -2.05M
EDVA EPS — quarterly -0.79
News
- 11 Consumer Staples Stocks Moving In Tuesday's After-Market Session
- Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use'
- Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
- Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
- Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On
- Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
- Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil
- Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
- Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
- Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday
Your note
Sign in to keep a note on EDVA — it syncs with the Stock Master app.